1.. INTRODUCTION {#S1}
================

Eimeriosis in cattle is an important enteric protozoan parasitosis which causes economic loss and severe clinical diseases in calves \[[@R8], [@R10]\]. As with several other pathogenic eimerian species that infect ruminants, the life cycle of *Eimeria bovis* includes the formation of macromeronts of up to 250 μm in size which develop in endothelial cells \[[@R13]\]. This lengthy process (14--18 days) is associated with the enlargement and reorganisation of the host cell (e.g. host cell cytoskeletal elements \[[@R16]\]). Parasite growth and proliferation within the parasitophorous vacuole (PV) requires nutrients from the host cell, as in other apicomplexa \[[@R7], [@R27]\]. Furthermore, given that endothelial cells generally represent a highly reactive cell type possessing a broad range of effector mechanisms capable of initiating pathogen elimination, *E. bovis* has to trigger a complex modulation of the host cell transcriptome and proteome to ensure its successful development. To date few details are known about the molecular mechanisms supporting long term survival of *E. bovis* or other macromeront forming *Eimeria* spp. within the host cell. Lang et al. \[[@R18]\] have recently shown that *E. bovis* prevents host cell apoptosis by up-regulating anti-apoptotic molecules. In avian *Eimeria* infections, modulation of epithelial host cell apoptosis was also achieved by expression of NFκB and the anti-apoptotic factor bcl-x~L~ \[[@R9]\]. Accordingly, up-regulation of NFκB was observed in sporozoite-infected, non-permissive epithelial host cells \[[@R2]\]. Comparative studies investigating the influence of different apicomplexa on the transcription of genes encoding for immunoregulatory molecules showed a relatively weak impact of *E. bovis* when compared to *Toxoplasma gondii* and *Neospora caninum* infections \[[@R30]\]. Interactions of *E. bovis*-infected endothelium with leukocytes were shown at the level of PBMC and PMN adhesion and seem to rely on infection-induced up-regulation of distinct adhesion molecules \[[@R15], [@R31]\].

Taken together, these few reports strongly suggest that *E. bovis* manipulates the host cell on a broad level involving different functional categories of host cell molecules. In order to gain a broad insight into *E. bovis*-induced host cell modulation with maximal coverage, we utilised a genome-wide approach using microarrays. We therefore analyzed *E. bovis*-induced gene regulation in in vitro infected endothelial host cells at distinct time points related to the development of the parasite, i.e., early after invasion by the sporozoite stage, at the trophozoite stage, at the beginning of parasite proliferation and when most mature meronts I were observed. Our microarray-based approach covered 23 000 known genes and uncharacterized expressed sequence tags. We show that with ongoing parasite development the number of regulated host cell gene transcripts increase and that modulated genes significantly interfere with various functions, networks and canonical pathways being mainly involved in cellular development, cell cycle, cell death, host cell immune response and metabolism of the host cell.

2.. MATERIALS AND METHODS {#S2}
=========================

2.1.. Parasite {#S3}
--------------

The *E. bovis* H strain used in the present study was maintained by passage in Holstein Friesian calves. Sporozoites were excysted from sporulated oocysts as previously described \[[@R14]\] and free sporozoites were collected and suspended at concentrations of 10^6^/mL in complete endothelial cell growth medium (ECGM, PromoCell, Heidelberg, Germany).

2.2.. Isolation, infection and harvesting of host cells {#S4}
-------------------------------------------------------

Bovine umbilical vein endothelial cells (BUVEC) used as host cells were isolated according to Taubert et al. \[[@R30]\]. Confluent BUVEC monolayers established in 75 cm^2^ culture tissue flasks were infected with 10^6^ *E. bovis* sporozoites. In order to account for individual variations and to have a rather robust setting, we worked with three different infected BUVEC isolates and respective non-infected BUVEC were analysed in parallel as negative controls. Infected BUVEC were harvested for RNA isolation 4 h, 4, 8 and 14 days post inoculation (p.i.) by direct lysis (1.2 mL lysis buffer/flask, RNeasy Mini Kit, Qiagen, Hilden, Germany).

2.3.. RNA extraction {#S5}
--------------------

Total RNA was isolated from BUVEC using the RNeasy-Kit (Qiagen) for isolation of total RNA according to the manufacturer's instructions. To minimise contamination with genomic DNA and to achieve reliable photometric measurements of the RNA, an on-column DNase I treatment (Qiagen) was applied during total RNA isolation following the manufacturer's instructions. The integrity of RNA was controlled by electrophoresis on a 1% (w/v) agarose gel. Since on-column DNase I treatment was not absolutely efficient, the extracted total RNA (1 μg) was additionally treated with RNase-free DNase I (0.5 μg DNase I/μg RNA, Fermentas, 15 min, room temperature). DNase I was inactivated afterwards by heating (65 °C, 10 min). Total RNA samples were then purified using the RNA cleanup protocol (RNeasy Mini Kit) and stored at −80 °C until further use.

2.4.. Microarrays {#S6}
-----------------

BUVEC expression pattern at the respective harvest time points were assessed using Affymetrix GeneChip bovine Genome Arrays (Affymetrix, High Wycombe, UK) representing 24 016 probe sets or genes that cover 16 813 transcripts annotated to NCBI's database Entrez Gene. Preparation of antisense biotinylated RNA targets from 5 μg of total RNA was done using the GeneChip Expression 3′Amplification On-Cycle Target Labelling and Control Reagents (Affymetrix) that involve 1st and 2nd strand cDNA synthesis and simultaneous in-vitro transcription and biotin labeling. Microarray hybridisation, washing and subsequent scanning were performed using an Affymetrix hybridisation oven, fluidic station and scanner respectively. The quality of hybridisation was assessed in all samples according to the manufacturer's recommendations. Data were analysed with Affymetrix GCOS 1.1.1 software using global scaling to a target signal of 500. Data were then imported into Arrays Assist software (Stratagene, Madrid, Spain) for subsequent analysis. The data were processed with MAS5.0 to generate cell intensity files (present or absent)[1](#FN2){ref-type="fn"}. Quantitative expression levels of transcripts were estimated using PLIER[2](#FN3){ref-type="fn"} for normalisation. Paired *t*-tests were done between the samples of the two treatment groups within the respective sampling times with three biological replicates. Differences were considered significant at *p* \< 0.05.

2.5.. Identification of significantly over-represented host cellular functions, networks and canonical pathways {#S7}
---------------------------------------------------------------------------------------------------------------

Individual, time-point-related lists of genes found to be significantly (*p* ≤ 0.05) up- or down-regulated in *E. bovis*-infected BUVEC were submitted to Ingenuity Pathway Analyses (IPA; Ingenuity^®^ Systems, Redwood City, CA, USA). Ingenuity maps gene IDs to its database and performs statistical computing to identify the most significant related functions, networks and canonical pathways over-represented in a given list when compared to the Ingenuity Pathways Knowledge Base which relies on millions of individually-modelled, peer reviewed pathway relationships. By default *p* ≤ 0.05 was used in all calculations. IPA computes a score for each network according to the fit of the network to the set of genes in question. The score is derived from a *p*-value and indicates the likelihood of focussed genes in a network being found together because of random chance. Gene symbols were coloured according to the respective regulatory state (red indicating up- and green down-regulation).

3.. RESULTS {#S8}
===========

3.1.. *E. bovis* in vitro infection {#S9}
-----------------------------------

In general, in vitro development of *E. bovis* corresponded to that described by Hermosilla et al. \[[@R14]\]. Infections of BUVEC with *E. bovis* sporozoites resulted in initial infection rates of 21.4 ± 5% (1 day p.i.). Infection controls conducted for up to 21 days p.i. revealed successful completion of meront I maturation and the production of merozoites I from days 17 p.i. onwards (Figs. 1E, 1F). On day 14 p.i. 7.1 ± 2.8% of BUVEC carried meronts I; intracellular sporozoites that had not undergone further development were detected in 6.9 ± 4.5% of the cells. However, some microscopic observations were noteworthy as they may directly be linked to the microarray results: immediately after invasion, intracellular sporozoites are generally situated close to the nucleus (Fig. 1A) which may indicate a direct influence on this organelle. Up to 4--7 days p.i., the nucleus of infected cells resembled that of non-infected cells showing a spotted content (Fig. 1B). From day 8 p.i. onwards, the morphology of the nucleus changed, resulting in a "fried-egg"-phenotype with increased proportions of light-coloured euchromatin and large coalescing/growing nucleoli (Figs. 1C--1F). This shape persisted until the release of merozoites I.Figure 1.*E. bovis* in vitro culture used for microarray analyses. Bovine endothelial cells were infected with *E. bovis* sporozoites. Parasite development was followed microscopically, illustrated here at 4 h (A), 4 (B), 8 (C), 14 (D), 17 (E) and 20 (F) days after infection. Note the enormous enlargement of the host cells (D--F) and the change in nucleus morphology (a--f) in infected cells into a "fried egg"-type. White solid arrow = intracellular sporozoite; black opened arrow = trophozoite (4 days p.i.), immature meront I (8 and 14 days p.i.); white opened arrow = merozoite I; black solid arrow = nucleus of infected cell (all 630× magnification). (A color figure is available at [www.vetres.org](http://www.vetres.org).)

3.2.. *E. bovis*-induced overall changes in host cell gene transcription {#S10}
------------------------------------------------------------------------

In general, the number of regulated genes increased with ongoing development of the parasite. Microarray analyses revealed a total of 12, 45, 175 and 1184 significantly ≥ 1.5-fold parasite-modulated host cell gene transcripts at the sampled time points (selected data in Tab. I). The proportion of up- and down-regulated gene transcripts varied with time after infection. The ten most modulated gene transcripts were all up-regulated and detected at 14 days p.i.Table I.Host cell gene transcription significantly modulated by *E. bovis* infection (selected).Functional classSymbolGeneFold change in transcription[\*](#TFN3){ref-type="fn"}4 h4 d8 d14 dTranscription/TranslationFOSv-fos FBJ murine osteosarcoma viral oncogene homolog2.451.691.971.82KLF4Kruppel-like factor 4----2.212.14KLF5Kruppel-like factor 5----1.512.60NR2F1Nuclear receptor subfamily 2, gr F, member 1----−1.69−2.55PRICKLE1Prickle homolog 1----2.052.97FHL2Four and a half LIM domains 2----1.983.88CAMTA1Calmodulin binding transcription activator 1------−2.74CRYMCrystallin, mu------4.12EIF4EEukaryotic translation initiation factor 4E----2.121.65MRPS6Mitochondrial ribosomal protein S6------3.46PPARGPeroxisome proliferator-activated receptor gamma------−2.77Signal transductionRND1Rho family GTPase 1----2.282.34SOCS1Suppressor of cytokine signaling----2.213.24DKK3Dickkopf homolog 3----1.733.96STK38LSerine/threonine kinase 38 like----1.693.05PPP1R1BProtein phosphatase 1, regulatory subunit 1B----−2.14−5.31PTGER4prostaglandin E receptor 4----−1.76−5.31RASD1dexamethasone-induced ras-related protein 1----−1.61−3.05FGL1Fibrinogen-like 1------−4.49GPR116G protein-coupled receptor 116------−2.65LGR4Leucine-rich repeat-containing G protein-coupled receptor 4------−2.65ARHGEF11Rho guanine nucleotide exchange factor 11------2.98APLP2Amyloid beta (A4) precursor-like protein 2------2.60PTPN1protein tyrosine phosphatase, non-receptor type 1------4.22RAB26Ras-related oncogene protein------2.77RASGEF1BRasGEF domain family, member 1B------−2.65RUVBL1RuvB-like protein 1------2.56CHPCalcineurin homologous protein------2.77SPARCL1SPARC-like 1------−2.65Nuclear proteinHIST2H2BEHistone cluster 2, H2BE--2.132.132.82SNRNP25Small nuclear ribonucleoprotein 25kDa------2.71Metabolism*Lipids*CYP51Cytochrome P450, family 51------3.59CH25HCholesterol 25-hydroxylase----2.263.14OLR1Oxidized low density lipoprotein receptor 1----2.142.72ELOVL5Elongation of long chain fatty acids member 5----1.732.64ELOVL6Elongation of long chain fatty acids member 6------2.85NAMPTNicotinamide phosphoribosyl-transferase----1.502.60ACOT7Acyl-Coenzyme A thioesterase 7----1.574.46IDI1Isopentenyl-diphosphate delta isomerase 1------7.74SCDStearoyl-Coenzyme A desaturase------5.26HMGCS1Hydroxy-methylglutaryl-Coenzyme A synthase 1------3.51ACAT2Acetyl-Coenzyme A acetyltransferase 2------2.99FASNFatty acid synthase------2.68FADS1Fatty acid desaturase 1------3.42FDPSFarnesyl diphosphate synthase------2.68FABPFatty acid binding protein 3------3.60PLD1Phospholipase D1------−2.66NSDHLNAD(P) dependent steroid dehydrogenase-like------2.69ACER3Alkaline ceramidase 3------2.62*Carbohydrates*GALTGalactose-1-phosphate uridylyltransferase----1.533.17STBD1Starch binding domain 1----2.114.35CHPFChondroitin polymerizing factor------4.80SULF2Sulfatase 2------3.20UGGT2UDP-glucose glycoprotein glucosyltransferase 2------3.17EXT1Exostoses (multiple) 1------2.51MTHFD1LMethylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like--1.632.8710.78MTHFD2Methenyltetrahydrofolate cyclohydrolase----2.053.06*Proteins*CYP1A1Cytochrom p450 1A16.35------PSAT1Phosphoserine aminotransferase 1--−1.521.932.96PSPHPhosphoserine phosphatase--−1.501.693.33GOT1Glutamic-oxaloacetic transaminase 1------3.79GPT2Glutamic pyruvate transaminase 2------2.89WDYHV1WDYHV motif containing 1------2.93*Nucleic acids*UPP1Uridine phosphorylase 1----2.242.94CTPSCytidine 5′-triphosphate synthetase------3.63RRM2Ribonucleotide reductase M2 polypeptide----1.836.70*Energy production*ME1Malic enzyme 1, NADP(+)-dependent, cytosolic------3.19MDH1Malate dehydrogenase 1------2.53*Other*KCNK1Potassium channel, subfamily K, member 1--1.852.373.22TMEM98Transmembrane protein 98--1.672.332.74SFXN1Sideroflexin 1------3.78TransportSLC25A33Solute carrier family 25, member 33----1.622.84SLC31A1Solute carrier family 31, member 1----1.916.50SLC25A4Solute carrier family 25, member 4------3.33SLC2A3Solute carrier family 2, member 3------3.35TINAGL1Tubulointerstitial nephritis antigen-like 1------3.51TFRCTransferrin receptor−1.54----2.51Cell cycleCCND2Cyclin D2----2.385.42CCNE1Cyclin E1----2.054.76PMP22Peripheral myelin protein 22----2.033.51S100A4S100 calcium binding protein A4----2.052.34S100A2S100 calcium binding protein A2--−1.53--2.55PTTG1Pituitary tumor-transforming protein 12.51Cell growth/proliferationTIMP2Tissue inhibitor of metalloproteinase 2----2.317.96CYR61Cysteine-rich, angiogenic inducer, 61----2.482.89EGR1Early growth response 12.37--2.651.84FGF1Fibroblast growth factor 1, acidic--2.132.252.77VEGFAVascular endothelial growth factor A----2.46--VEGFCVascular endothelial growth factor C----2.0722.23CSRP2Cysteine and glycine-rich protein 2----1.7211.25SERPINE2Serpin peptidase Inhibitor, clade E member 2------2.86CD320CD320 molecule------2.85Cell structureCOL1A2Collagen, type I, alpha 2--−2.57--−2.22FGD4FYVE, RhoGEF and PH domain containing 4----−1.51−3.13PALLDPalladin, cytoskeletal associated protein------3.64MAP1BMicrotubule-associated protein 1B------3.23TUBBTubulin, beta------2.90Cell adhesionSELPSelectin P----2.297.23VCAM1Vascular cell adhesion molecule 1----2.18--THBSThrombospondin 1--−1.672.051.52THBS2Thrombospondin 2--−1.632.131.62LGALS1Lectin, galactoside-binding, soluble, 1----1.7111.61TPBGTrophoblast glycoprotein----1.583.60CLDN16Claudin 16------−2.70PARVBParvin, beta------2.71LAMA3Laminin, alpha 3------−2.61Stress responseUSP2Ubiquitin specific peptidase 2------−3.92SERPINH1Serpin peptidase Inhibitor, clade H member 1----1.513.03ApoptosisDRAMDNA-damage regulated autophagy modulator 1----−1.62−3.20CYCSCytochrome c, somatic------2.90TIMP4Tissue inhibitor of metalloproteinase 4----−1.65−3.28Immune responseIFI30Interferon-gamma-inducible protein 30----1.6624.16IL8Interleukin-8----3.75--CXCL5Chemokine (C-X-C motif) ligand 5----3.63--CXCL1Chemokine (C-X-C motif) ligand 1----2.52--CCL26Chemokine (C-C motif) ligand 26----2.111.63CXCR4Chemokine (C-X-C motif) receptor 4------−2.71SERPINE1plasminogen activator inhibitor-1--−1.533.19--PLAUPlasminogen activator, urokinase--1.902.641.88PLATplasminogen activator, tissue----1.548.77C3Complement component 3----2.542.60CFBComplement factor B----2.782.50C1QBPComplement component 1, q subcomponent binding protein------2.56CD200CD200 molecule------6.51TAP1Transporter 1, ATP-binding cassette, sub-family B3.49Unknown functionTM4SF18Transmembrane 4 L six family member 1------3.28SYNGR2Synaptogyrin 2----1.615.93DBNDD2Dysbindin (dystrobrevin binding protein 1) domain containing 2----1.793.26FIBINFin bud initiation factor homolog----1.61−3.09GLIPR2GLI pathogenesis-related 2----2.063.00B9D1B9 protein domain 11.552.75GPM6BGlycoprotein M6B------−3.17PALDKIAA1274------−2.89HIGD1DHIG hypoxia inducible domain family, member 1D------2.62SELMSelenoprotein M------2.85[^1]

The proportion of molecules commonly regulated in the course of infection was generally low early after infection but increased later on. FOS was the only gene transcript significantly up-regulated ≥ 1.5-fold at all four time points. Considering the last three time points, an overlapping gene subset of 17 molecules was influenced by *E. bovis* infection on days 4, 8 and 14 p.i. Comparing data generated on days 4 vs. 8 and 4 vs. 14 p.i., 7 additional molecules overlapped each. Additionally, 94 molecules overlapped when comparing regulated gene transcripts on days 8 vs. 14 p.i., with 63% of the molecules modulated at day 8 p.i. being equally influenced 6 days later. Within this set of common molecules, in 82%, the transcription was even enhanced 14 days p.i.

3.3.. Functional analyses of gene sets regulated by *E. bovis* {#S11}
--------------------------------------------------------------

### 3.3.1.. Predicted functional effects {#S12}

IPA revealed various host cell biofunctions to be significantly regulated by *E. bovis* infection, the majority of which dealt with general cell-related functions (Fig. 2), metabolism/biosynthesis (Fig. 3) and immune response (Fig. 4). In general, an increasing probability of involvement was associated with ongoing infection. It is noteworthy that regulation of the cell cycle was clearly enhanced in the late phase of infection on 8 and 14 days p.i. Genes associated with metabolism/biosynthesis-related functions included many involved in carbohydrate metabolism, molecular transport and small molecule biochemistry (Fig. 3). In addition, late *E. bovis* infection (14 days p.i.) significantly regulated molecules involved in lipid metabolism, nucleic acid metabolism and energy production. *E. bovis* infection also altered the host cell immune response. Whilst major reactions related to immune cell trafficking and inflammatory response were restricted to 8 days p.i., molecules involved in cell-mediated immune response and antigen presentation were significantly affected 4--14 days p.i. (Fig. 4). A more precise overview detailing the number of genes involved in host cell functions and respective *p*-values as well as identified molecules involved in different functions is given in the Supplementary Tables I and II, respectively, available on line only.Figure 2.Biofunctions related to general cell characteristics significantly affected in endothelial host cells by *E. bovis* infection. A Fisher's exact test was used to calculate a *p*-value (bars) determining the probability that the association between the genes in the different datasets (4 h p.i. = dark blue bars, 4 days p.i. = medium blue bars, 8 days p.i. = bright blue bars, 14 days p.i. = black bars) and the respective biofunctions can be explained by random chance. The threshold (yellow line) refers to the cut off for *p* ≤ 0.05. (A color figure is available at [www.vetres.org](http://www.vetres.org).) Figure 3.Metabolism-related biofunctions significantly regulated in endothelial host cells by *E. bovis* infection. A Fisher's exact test was used to calculate a *p*-value (bars) determining the probability that the association between the genes in the different datasets (4 h p.i. = dark blue bars, 4 days p.i. = medium blue bars, 8 days p.i. = bright blue bars, 14 days p.i. = black bars) and the respective biofunctions can be explained by random chance. The threshold (yellow line) refers to the cut off for *p* ≤ 0.05. (A color figure is available at [www.vetres.org](http://www.vetres.org).) Figure 4.Biofunctions related to immune responses significantly affected in endothelial host cells by *E. bovis* infection. A Fisher's exact test was used to calculate a *p*-value (bars) determining the probability that the association between the genes in the different datasets (4 h p.i. = dark blue bars, 4 days p.i. = medium blue bars, 8 days p.i. = bright blue bars, 14 days p.i. = black bars) and the respective biofunctions can be explained by random chance. The threshold (yellow line) refers to the cut off for *p* ≤ 0.05. (A color figure is available at [www.vetres.org](http://www.vetres.org).)

### 3.3.2.. Predicted signaling pathways {#S13}

The most significantly affected pathway was the aryl hydrocarbon receptor signalling pathway, which was significantly over-represented in *E. bovis*-infected cells at 4 h, 8 and 14 days p.i. (Tab. II). It is noteworthy that two signalling pathways referring to cell cycle regulation (G1/S checkpoint regulation, G2/M checkpoint DNA damage regulation, 8 and 14 days p.i.) and stress response (NRF2-mediated oxidative stress response, 14 days p.i.) were exclusively over-represented by regulated genes in the late phase of *E. bovis* infection.Table II.Canonical pathways significantly over-represented by *E. bovis*-regulated genes in infected bovine endothelial host cells (*p* ≤ 0.05).Canonical Pathway[a](#TFN1){ref-type="fn"}p.i.MoleculesAryl Hydrocarbon Receptor Signaling4 hFOS, CYP1A18 dNR2F1, MYC, FOS, CCNE1, CCND2, TGFB214 dGSTM1, MGST1, CCNE2, GSTP1, IL6, MYC, NR2F1,\
FOS, CCNE1, JUN, CCND3, CCND2, SP1,\
CDKN1A, ALDH1A2, TGFB2, HSP90AA1, ALDH18A1, HSPB1, GSTK1HMGB1 Signaling4 dFOS, SERPINE18 dIL8, FOS, VCAM1, ICAM1, SERPINE1, PLAT14 dKAT2B, FOS, JUN, MAPK14, SP1, CDC42,\
RBBP7, MRAS, IFNGR2, PIK3R2, PLATHGF Signaling14 dMAP3K11, CDC42, PLCG1, IL6, FOS, JUN,\
GAB1, CDKN1A, MRAS, PRKCH, MAP3K8, PIK3R2,\
ELK3, MAP3K3IGF-1 Signaling4 dFOS, IGFBP5, NEDD414 dFOS, YWHAG, JUN, NOV, YWHAH, MRAS,\
RPS6KB2, IGFBP5, PRKCH, PIK3R2, CYR61, GRB10ERK5 Signaling4 hFOS14 dMYC, FOS, YWHAG, YWHAH, GAB1, MRAS,\
RPS6KB2, MAP3K8, MEF2C, RPS6KA5, MAP3K3NRF2-mediated Oxidative Stress Response14 dAKR7A2, GSTM1, GSTP1, USP14, MGST1, DNAJC3,\
DNAJA1, FOS, MAPK14, SOD2, JUN, SCARB1,\
STIP1, MRAS, UBE2K, DNAJC1, PRKCH, PIK3R2,\
DNAJB6, GSTK1Protein Ubiquitination Pathway14 dPSMB9, UCHL3, USP14, PSMB5, PSMD7, PSMC4,\
USP54, THOP1, UBE2S, HSPA5, USP2, PSMB6,\
TAP1, PSMD8, UBE2F, UCHL1, HSPA8, USP53,\
PSMB2, HSP90AA1, PSMD14, USP40, UBE2E1Acute Phase Response8 dSOCS1, FOS, SOD2, C1S, NOLC1, CFB, SERPINE1Leukocyte Extravasation Signaling8 dTIMP4, VCAM1, ICAM1, EZR, TIMP214 dTIMP3, CDC42, CXCR4, MMP16, PLCG1, RAPGEF3,\
WIPF1, TIMP4, MAPK14, CDH5, CLDN1, EZR,\
CYBA, CLDN16, CD44, MMP11, PRKCH, PIK3R2,\
VCL, TIMP2IL-8 Signaling8 dIL8, VCAM1, ICAM1, CCND2, CXCL1, VEGFCCoagulation System4 dPLAUR, PLAU, SERPINE18 dPLAUR, PLAU, SERPINE1, PLATCell Cycle: G1/S Checkpoint Regulation8 dMYC, CCNE1, CCND2, TGFB214 dMYC, CCNE2, CCNE1, CCND3, HDAC3, CCND2,\
CDKN1A, TGFB2Cell Cycle: G2/M DNA Damage Regulation8 dTOP2A, CCNB2, BRCA114 dKAT2B, GADD45A, PTPMT1, CDKN1A, TOP2A, CCNB2[^2]

### 3.3.3.. Predicted gene networks {#S14}

IPA constructed 1, 3, 9 and 25 inter-connected gene networks that were significantly altered as a result of *E. bovis* infection 4 h, 4, 8 and 14 days after infection, respectively.

The most significant network over-represented by *E. bovis*-regulated genes at 4 days p.i. concerned cardiovascular system development/function, organ morphology and organismal functions (Supplementary Fig. 1, available online at [www.vetres.org](http://www.vetres.org)) focussing on the transcription regulators FOS and ANKRD1.

The most significant network at 8 days p.i. referred to cellular movement, immune cell trafficking and host cell inflammatory response (Fig. 5A). Out of 35 network-forming molecules, 18 were modulated by *E. bovis* infection and all were up-regulated. Up-regulation especially concerned chemokines (IL-8, CXCL1, CXCL3, CXCL6) and adhesion molecules (VCAM1, ICAM1), but also focussed on the regulation of coagulation (PLAU, PLAUR, PLAT, SERPINE1).Figure 5.Molecular networks over-represented by *E. bovis*-regulated host cell molecules 8 (A) and 14 (B) days after in vitro infection. A list of significantly (*p* ≤ 0.05) regulated molecules in *E. bovis*-infected endothelial host cells 4, 8 and 14 days after infection was individually subjected to Ingenuity Pathway Analyses which generated highly significant networks displaying up-regulated molecules in red and down-regulated ones in green. (A) Network on molecules involved in cellular movement, immune cell trafficking and inflammatory response (8 days p.i.). (B) Network on molecules involved in cellular assembly and organisation, gene expression and infection mechanism (14 days p.i.). (A color figure is available at [www.vetres.org](http://www.vetres.org).)

The most significant network at 14 days p.i. concerned cellular organisation, gene expression and infection mechanisms (Fig. 5B). All network-forming genes were modulated by *E. bovis* infection resulting in a MYC-centered gene network with the majority of genes being up-regulated.

Another network significantly influenced by *E. bovis* infection referred to the regulation of cell cycle, cellular development, cellular growth and proliferation (Supplementary Fig. 2, available online at [www.vetres.org](http://www.vetres.org)). In this network a high number of transcription regulators (SOX18, KLF4, KLF5, ID3, MEF2C, PHB) were affected.

4.. DISCUSSION {#S15}
==============

In this investigation we performed a transcriptional profiling of *E. bovis*-infected host endothelial cells to obtain global insights into parasite-triggered host cell modulation. Considering the total number of regulated genes and the overlapping gene sets, it appears that in vitro development of meronts I can be divided into an early phase (4 h, 4 days p.i.) with poor regulatory processes on the transcriptional level and a more transcriptionally active late phase (8, 14 days p.i.) beginning with the onset of parasite proliferation.

The in vitro culture used in this investigation corresponded well with the host cell type, the duration of meront I development and the resulting size of these stages to those reported in vivo \[[@R13]\]. The reduction of infection rates with progression of infection may result from the consistent observation that not all sporozoites having successfully invaded host cells undergo further development in vitro which agrees with ex vivo histological studies on *E. bovis*-infected ileum mucosa[3](#FN4){ref-type="fn"} and those reported for other *Eimeria* spp. infections \[[@R25]\]. Furthermore, as reported for other apicomplexan-infected host cells \[[@R29]\], some vital early meronts reproducibly disintegrate from the cell layer and are lost during the following cell feeding procedure. Taken together, these facts indicate that the in vitro system used in this investigation relates to the situation in vivo.

To assure that the regulation of gene transcription was parasite-induced and to exclude effects based on cell aging processes we performed non-infected control samples for every time point and every BUVEC isolate. Direct comparisons of infected BUVEC isolates with the respective non-infected cells revealed significant parasite-driven effects. Given that with progression of infection the number of regulated genes increases -- although less infected cells carrying respective stages were detected -- demonstrates stage-specific, parasite-triggered modulation. The fact that identical molecules regulated 8 and 14 days p.i. are mostly found to be increased in their gene transcription at the later time point strengthens enhanced parasite-driven host cell regulation towards the end of merogony I.

The observed changes in host cell nucleus morphology coincided with increasing numbers of regulated genes during the late phase of *E. bovis* infection. Enhanced transition of hetero- to euchromatin is indicative of a transcriptionally active cell and was exclusively observed from 8 days p.i. onwards. The finding that most regulated gene transcripts were detected 8 and 14 days p.i. supports this hypothesis. Among these transcripts, some key regulators of gene transcription (FOS, MYC, STAT1) and various other transcription factors (ANKRD1, ANKRD52, BHLHB2, GTF2E2, GTF2H3, EZH2, KLF4, KLF5) were up-regulated. Especially the MYC-centred gene network generated at 14 days p.i., which indicates high transcriptional activity of *E. bovis*-infected host cells.

An intriguing morphological observation was the consistent arrest of the nuclear "fried-egg"-morphology after this status had appeared. In non-infected cells this morphology indicates the interphase of a cell which changes again as soon as the cell displays mitotic activity \[[@R1]\]. In *E. bovis*-infected endothelial cells, the morphology remained stable irrespective of ongoing development or host cell type, an observation that has also been made for a macromeront-forming *Eimeria* species of the goat, *Eimeria ninakohlyakimovae* [4](#FN5){ref-type="fn"}. Overall, this phenomenon may indicate a parasite-induced arrest in cell cycle from 8 days onwards. Accordingly, the predicted influence of *E. bovis*-regulated genes on the cell cycle was of a higher significance at days 8 and 14 p.i. than at earlier time points. This was also reflected in the signalling pathways on G1/S checkpoint regulation and G2/M checkpoint DNA damage regulation which were over-represented in *E. bovis*-infected host cells. However, when considering total parasite-triggered modulation of the cell cycle regulatory machinery, both cell cycle progress and arrest seem to have been affected. Up-regulation of different cyclins (CCNB2, CCND2, CCNE1, CCNE2) and related molecules (CDK2AP1, GADD45A), as well as down-regulation of the cyclin-dependent kinase inhibitor 1C, favour cell cycle progress \[[@R22]--[@R24], [@R28]\]. In contrast, down-regulation of CCND3 and up-regulation of inhibitory molecules (CDKN1A, BRCA1) argues for a cell cycle arrest \[[@R11], [@R20], [@R24], [@R33], [@R34]\].

Once the parasite starts to grow and divide within the cell, it must acquire nutrients through or from the host cell. In contrast to *T. gondii*, which exhibits well-documented auxotrophies for purines \[[@R17]\], hypoxanthine, xanthine and other molecules \[[@R26]\], no data are available for the nutritional requirements of *E. bovis* or other eimerian species. Although different metabolic categories, such as carbohydrate, lipid and nucleic acid metabolism, were significantly modulated by *E. bovis* infection at almost all time points investigated, overall, most metabolism/biosysnthesis-related molecules were influenced at 14 days p.i. (i.e. when parasite proliferation was fully active). Genes up-regulated in infected host cells were then involved in pathways of carbohydrate biosynthesis and metabolism such as amino sugar, fructose/mannose, galactose, nucleotide sugar and pyrovate metabolism as well as in glycolysis/gluconeogenesis and the pentose phosphate pathway, indicating that transcriptional alteration of the basic host cell metabolism is pivotal for intracellular growth of meronts I.

*T. gondii* has to scavenge host cholesterol since it cannot synthesize sterols de novo via the mevalonate pathway \[[@R7], [@R27]\]. Interestingly, 16 molecules involved in cholesterol biosynthesis and metabolism were significantly up-regulated in *E. bovis*-infected host cells 14 days p.i., which may indicate comparable nutritional needs in both parasites. Most notable was the up-regulation of squalene epoxidase (SQLE), which is reported to be one of the rate-limiting enzymes in the mevalonate pathway and which was also induced in porcine and human *T. gondii*-infected host cells \[[@R6], [@R21]\].

At 14 days p.i., molecules contributing to the metabolism of malic acid (MDH1, MDH2, ME1) were also up-regulated in infected cells, indicating an increased need for energy production towards the end of merogony I.

*E. bovis* meront I development within the endothelial cell generally leads to enormous alteration of host cell characteristics concerning cell size and subcellular organisation. Hermosilla et al. \[[@R16]\] reported an increasing influence on actin- and tubulin-related reorganisation of the host cell cytoskeleton with ongoing infection. We now found enhanced gene transcription of several tubulins (TUBB, TUBB4, TUBB6) and of molecules involved in microtubule binding or cytoskeleton organisation (TPPP, DOCK7, CKAP4, DCT3) in the late phase of infection. Also vinculin and ezrin, molecules involved in actin cytoskeleton signalling, and other actin-related genes (CAPG, CNN2, TAGLN, PALLD) were up-regulated at the meront I stage and may contribute to the cytoskeleton re-structuring process induced by the formation of this parasitic stage.

The vast reorganisation and enlargement of *E. bovis* infected host cells in the late phase of meront I formation causes considerable cell stress, which is reflected in up-regulation of several heat shock proteins (HSP90AA1, HSP90B1, HSP70, HSP70-3, HSP70-5, HSP27, HSPB6) and other stress-related molecules, such as SERP1 and STIP1 at day 14 p.i. The latter coordinates the functions of HSP70 and HSP90. HSP are also closely linked to host cell apoptosis, since certain members exhibit anti-apoptotic effects via both the receptor-mediated pathway and the inner, mitochondrial pathway \[[@R3], [@R4]\]. It is well known that intracellular stages of other apicomplexan parasites modulate host cell apoptosis to guarantee successful intracellular development (for review see \[[@R12]\]). Lang et al. \[[@R18]\] have recently shown that *E. bovis-*infected cells are defended from apoptosis by enhanced expression of the anti-apoptotic molecules c-FLIP and c-IAP1. The current data confirm up-regulation of c-IAP at 8 days p.i. and provide new candidates repressing apoptosis, either by their up-regulation (DDIT4, BCL2A1) or by decreased abundance (BOK). However, the modulated abundance of several other molecules rather argues for enhanced host cell apoptosis (BAG5, BAK1, BCL2L14, CYCS, COX5A, DAP3).

Previous work has shown that interactions of *E. bovis* and endothelial cells result in inflammatory processes associated with the adhesion of PMN \[[@R15]\] and PBMC \[[@R31]\] to infected cell layers and enhanced transcription of genes encoding for immune-modulatory molecules \[[@R30]\]. The enhanced host cell immune responses described here support these reports, most notably on day 8 p.i. when a respective gene network was generated involving various up-regulated chemokines, adhesion molecules and factors of coagulation. Interestingly, all up-regulated chemokines belonged to the CXC-family (CXCL1, CXCL3, CXCL6, CXCL8), molecules predominantly acting on PMN and/or lymphocytes \[[@R19], [@R35]\], both of which are stimulated in *E. bovis* infections \[[@R5], [@R32]\]. Up-regulation of the adhesion molecules VCAM1, ICAM1 and SELP may directly contribute to the above mentioned adhesion of leukocytes to infected cell layers \[[@R15], [@R31]\].

The precise role of molecules involved in coagulation (i.e. PLAU, PLAUR, PLAT, SERPINE1), in *E. bovis* infection is not known. Given that pro-inflammatory reactions at the endothelial site are generally accompanied by enhanced permeability of cell layers, activation of the coagulation system may represent an additional sign of parasite-triggered endothelial cell activation. The induction of CFB, CFH, C1S and C3, molecules involved in the complement cascade, may also be seen in this sense. Overall, the inflammatory response at 8 days p.i. was also reflected in regulated canonical pathways in *E. bovis*-infected host cells. Involvement in IL-8 signalling, leukocyte extravasation signalling and in the coagulation system has already been mentioned above. Moreover, *E. bovis* infection induced HMBG1 signalling on days 4, 8 and 14 p.i., a pathway leading to the release of pro-inflammatory molecules.

In conclusion, the current investigation has identified numerous gene transcripts regulated by *E. bovis* during in vitro infection for the first time. The induction of cholesterol- and carbohydrate-related pathways shed light on *Eimeria*-associated nutritional needs for intracellular growth. Various indications from transcripts associated with host cell apoptosis, immune response and cell cycle regulation provide useful tools for more detailed, prospective studies on *Eimeria*-host cell interactions.
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